Publication | Open Access

Tumor mutational analysis of GOG248, a phase II study of temsirolimus or temsirolimus and alternating megestrol acetate and tamoxifen for advanced endometrial cancer (EC): An NRG Oncology/Gynecologic Oncology Group study

Advanced Endometrial CancerMegestrol AcetateMedicineGynecologyPathologyTumor Mutational AnalysisCancer TreatmentOncologyGynecology OncologyTumor BiologyEndocrine-related Cancer